Microsoft strikes deal with Merck for Rosetta Biosoftware assets |
Connect with TechFlash on our Facebook page for all the latest technology news headlines and commentary, plus information and access to special events, photos from events, promotions and more.
Today On Techflash
- Paul Allen's Vulcan wants taller South Lake Union buildings
- Apple seen unveiling iPad 3 in first week of March
- Microsoft, Apple speak out on patents amid mobile-technology wars
- What's the most you'll pay for an app? Execs have their limits
- Startup seeks a new start: What's next for EquaShip?
- WTIA announces Industry Achievement Award finalists
- Startup seeks a new start: What's next for EquaShip?
- UW opens New Ventures Facility for startups
- Pioneer Square: a little fiber to go with all that brick
- 'Fast Pitch Forum' to debut May 27 with some familiar names
- What's the most you'll pay for an app? Execs have their limits
- WTIA announces Industry Achievement Award finalists
Mass High Tech
- Microsoft Build: Windows 8 preview a hit, but are investors unhappy?
- Build an app in a day at Mobile App Hackathon
- Beefed-up Skype for Windows; Indie author joins Amazon's 'Kindle Million Club'
- Only solution to Xbox 360 update error is new console
- Ballmer: Windows Phone update 'Mango' has over 500 new features
Microsoft strikes deal with Merck for Rosetta Biosoftware assets
Microsoft today agreed to buy assets of Rosetta Biosoftware from biotech giant Merck, bolstering the Redmond company's push into life-sciences technology. Microsoft says the deal will let it incorporate new biotech software into its Amalga Life Sciences system.
In addition, Merck will become an Amalga Life Sciences customer, and help Microsoft incorporate and use the Rosetta technology.
Rosetta Biosoftware is part of Rosetta Inpharmatics, a Seattle-based biotech company that Merck acquired in 2001. Last year, Merck announced plans close the most of the 300-person Rosetta Inpharmatics unit in Seattle's South Lake Union neighborhood by the end of 2009, but Rosetta Biosoftware was expected to continue operating, with about 60 employees.
With today's deal, Microsoft says it's looking to hire some Rosetta Biosoftware employees in key positions.
The Microsoft agreement "establishes a stable and sustainable platform for the Rosetta Biosoftware technology. In addition, we look forward to collaborating with Microsoft to develop new bioinformatic solutions to enable and expedite drug discovery and development,” said Rupert Vessey, vice president, Merck Research Laboratories, in the news release announcing the deal.
Financial terms weren't disclosed. The purchase is expected to be complete at the end of this month, and Microsoft says a new version of Amalga Life Sciences, incorporating Rosetta Biosoftware's technologies, will be available early next year.
Update, 3:30 p.m.: The "build vs. buy" decision was easy in this case, said Jim Karkanias, senior director of applied research and technology for Microsoft's Health Solutions Group, in a phone interview this afternoon. By purchasing the Rosetta Biosoftware assets, he said, Microsoft will be able to incorporate about 10 years of work into the Amalga Life Sciences product offering.
"This is a significant value driver for us," he said.
Microsoft will interview Rosetta employees in hopes of finding good roles for them. Despite the presence of Microsoft operations in the South Lake Union area, people who are hired will be working out of Redmond, he said.
Separately, Karkanias said this acquisition was not the reason Microsoft registered a new LLC (limited liability company) in Delaware recently. That registration has sparked speculation about a possible acquisition. For now, its purpose remains a mystery.
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
TechFlash Team
Recent Sponsor Posts
Who's creating today's energy efficient buildings? Find out at the BetterBricks Awards, Feb. 16
BetterBricks Awards salute the individuals leading the way for high performance commercial buildings with an emphasis on energy efficiency. Join us as we recognize these standout green building professionals.
Award categories include: Advocate; Architect/Designer; Facility Manager/Operator; and Owner/Developer.
Keynote Speaker: Kevin Kampschroer, Director of U.S. GSA's Office of Federal High Performance Buildings. Kevin leads the U.S. General Services Administration's efforts in building sustainability and accelerating industry adoption of sustainable principles across all aspects of a building's life.
Register here by February 10!
If you are interested in buying a table, email Monica Alquist or call her at 206-876-5404.
The Triple Door Presents: The Atomic Bombshells "J'ADORE!: A Burlesque Valentine"
Seattle's reigning Burlesque super-troupe delivers a gorgeous and glittering VALENTINE featuring some of the Bombshells' most exhilarating acts to date. J'Adore! promises to celebrate l'amour with good humor, style, and a healthy dose of dazzle! Bring a friend, a lover, a family member, or a secret crush, and celebrate with the Valentine's Burlesque spectacular that will leave you shouting: "J'ADORE......The Atomic Bombshells!" The incomparable Jasper McCann emcees with high style and charm.
Please visit www.thetripledoor.net for a full schedule of future performances.
The Triple Door Presents: Bob Mould – See A Little Light: An Evening of Reading and Music
"Bob Mould. Those two words are synonymous with integrity. From Husker Du in the last century to right at this moment, Bob is the real deal, writing and playing music for music's sake. He's a great songwriter and performer. I have been a fan of Bob's for thirty years now with no end in sight." -Henry Rollins
Please visit www.thetripledoor.net for a full schedule of future performances.
Why Choose BDO for your SOC (previously SAS 70) Reports?
BDO’s experience in providing attestation services (SAS 70/SSAE 16, AT 101, AT 201, AT 601, etc.) to a broad range of industries, and our team of skilled professionals distinctly qualifies us to serve as your company’s Service Auditor. By leveraging the BDO global network of control specialists, we are poised to provide global services in more than 1,000 offices and across 119 countries. Many organizations find that investing in reports on controls may result in benefits, including:
• Increased client confidence
• Improved competitive advantage
• Minimization of frequent audits
• Streamlined business processes and controls
• Enhanced risk management
For detailed information contact Paul Martini at pmartini@bdo.com.
